Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for ALNYLAM PHARMACEUTICALS, INC., €355k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Supran Bryan: trading record in brief
One trade, one date: on 2 October 2026, Supran Bryan disclosed a transaction of €355k in Alnylam Pharmaceuticals, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Supran Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
1,758 shares@ US$226.8841CommonSEC144:0001959173-26-007216
1 of 1 declaration
